Skip to main content

Table 8 Data on Health Utilization costs (n EUR)

From: Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

 

Visits to emergency unit

Emergency visit costs*

Hospitalization Days**

Hospitalization costs*

Follow-up visits

Follow-up costs*

Genetic testing costs*

PGx-guided arm

13

664.30

9

7522.49

15

101.65

120

Control arm

17

1146.65

11.3

11,593.33

24

199.31

0

  1. *Average cost per arm, ** Average number of hospitalization days
Back to article page

Human Genomics

ISSN: 1479-7364